9

VanEck Genomics and Healthcare Innovators UCITS ETF
Ordredybde
Generell informasjon
- Total pris0,35%
- Aktiva klasseAksje
- KategoriBransjefond, Helsevern
- Basis-valutaEUR
- UtbyttepolicyAkkumulert
- Nøkkelinformasjon
The Fund’s investment objective is to replicate the price and the performance, before fees and expenses, of an index that provides exposure to the performance of a representative portfolio of companies involved in the genomic healthcare and electronic healthcare industries.
Relaterte ETFer
Eksponering
Fordeling
- Aksjer100%
Kunder besøkte også
Forum
Nyheter
Generell informasjon
- Total pris0,35%
- Aktiva klasseAksje
- KategoriBransjefond, Helsevern
- Basis-valutaEUR
- UtbyttepolicyAkkumulert
- Nøkkelinformasjon
The Fund’s investment objective is to replicate the price and the performance, before fees and expenses, of an index that provides exposure to the performance of a representative portfolio of companies involved in the genomic healthcare and electronic healthcare industries.
Relaterte ETFer
Nyheter
Ordredybde
Eksponering
Fordeling
- Aksjer100%
Kunder besøkte også
Forum
Generell informasjon
- Total pris0,35%
- Aktiva klasseAksje
- KategoriBransjefond, Helsevern
- Basis-valutaEUR
- UtbyttepolicyAkkumulert
- Nøkkelinformasjon
The Fund’s investment objective is to replicate the price and the performance, before fees and expenses, of an index that provides exposure to the performance of a representative portfolio of companies involved in the genomic healthcare and electronic healthcare industries.
Relaterte ETFer
Nyheter
Forum
Ordredybde
Eksponering
Fordeling
- Aksjer100%
